ZEVRA THERAPEUTICS, INC. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Zevra Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Zevra Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $123K, a 13.4% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $552K, a 5.75% increase from 2022.
  • Zevra Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $522K, a 13.5% increase from 2021.
  • Zevra Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $460K, a 2.91% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $123K -$19K -13.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $142K +$25K +21.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $117K +$3K +2.63% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $114K +$5K +4.59% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $109K +$1K +0.93% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 $108K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.